SB129Introduced in the Senate
An Act To Amend Title 16 Of The Delaware Code Relating To Prescription Opioid Funds And Litigation Authority.
Introduced by Stephanie Hansen, District 10
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
An Act To Amend Title 16 Of The Delaware Code Relating To Prescription Opioid Funds And Litigation Authority.
Where it stands
Signed by Governor
July 21, 2025
How did lawmakers vote?
House votes
1 recorded vote · each counted separately
Senate votes
1 recorded vote · each counted separately
HouseStage: House Third Reading · June 25, 2025
39
Yes
0
No
1
Absent or Not Voting
40 representatives recorded in this House vote. Colors show vote categories only, not whether a vote was good or bad.
What do people think?
Citizen Voice
How would you vote on this bill?
An unofficial public opinion poll. It does not affect the bill or the official vote.
One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.
See how each representative voted
| Representative | District | Vote |
|---|---|---|
| Nnamdi Chukwuocha | 1 | Yes |
| Stephanie Bolden | 2 | Yes |
| Josue Ortega | 3 | Yes |
| Jeff Hilovsky | 4 | Yes |
| Kendra Johnson | 5 | Yes |
| Debra Heffernan | 6 | Yes |
| Larry Lambert | 7 | Yes |
| Sherae'a Moore | 8 | Yes |
| Kevin Hensley | 9 | Yes |
| Melanie Ross Levin | 10 | Yes |
Bill history
Introduced and Assigned to Health & Social Services Committee in Senate
Reported Out of Committee (Health & Social Services) in Senate with 8 Favorable
Passed By Senate. Votes: 19 YES 2 ABSENT
Assigned to Health & Human Development Committee in House
Reported Out of Committee (Health & Human Development) in House with 5 Favorable, 5 On Its Merits
Passed By House. Votes: 39 YES 1 ABSENT 1 VACANT
Signed by Governor
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.